Financials data is unavailable for this security.
View more
Year on year Redsense Medical AB (publ) grew revenues 74.11% from 14.34m to 24.97m while net income improved from a loss of 8.76m to a smaller loss of 4.51m.
Gross margin | 20.47% |
---|---|
Net profit margin | -16.72% |
Operating margin | -16.54% |
Return on assets | -12.58% |
---|---|
Return on equity | -14.51% |
Return on investment | -14.51% |
More ▼
Cash flow in SEKView more
In 2023, Redsense Medical AB (publ) increased its cash reserves by 89.71%, or 3.29m. Cash Flow from Investing totalled 8.35m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 5.05m for operations while cash from financing was breakeven.
Cash flow per share | -0.2717 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.95 |
---|---|
Tangible book value per share | 1.08 |
More ▼
Balance sheet in SEKView more
Current ratio | 4.86 |
---|---|
Quick ratio | 4.00 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼